Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAFTS: Rhythm vs Rate Control for New Onset AF in Septic Shock
NCT04092621Phase 4Unknown
- Sponsor
- Our Lady of the Lake Regional Medical Center
- Start
- Sep 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amiodarone in atrial fibrillation (AF) (2 arms), sponsored by Our Lady of the Lake Regional Medical Center. Primary endpoints: ICU Length of Stay at 28 days, Ventilation-free days at 28 days and 1 more. Status: unknown.
02
Drugs
amiodarone
03
Conditions
atrial fibrillation (AF)
Beyond the preview
Go deeper on NCT04092621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04092621.